Monday, June 5, 2023 Drug prolongs time before brain tumour grows back
As part of the Phase 3 clinical trial, research participants with low-grade gliomas, taking the drug vorasidenib remained free from tumour re-growth for 27.7 months, as of the time of study read-out.
Monday, December 5, 2022 Upper abdominal patient receives first treatment on MR-Linac – Elekta Unity
This technology is the first machine in the world to combine radiation and high-resolution magnetic resonance imaging (MRI).
Thursday, November 17, 2022 Two Sunnybrook scientists awarded Canada Research Chairs
Two Sunnybrook Research Institute (SRI) scientists have been recognized with the country’s highest research honour, a Canada Research Chair (CRC). Dr. Burton Yang, a senior scientist in Biological Sciences and the Odette Cancer Research Program, and Dr. Maged Goubran, a scientist in Physical Sciences and the Hurvitz Brain Sciences Research Program, were announced as chairholders on November 16, 2022.
Wednesday, November 2, 2022 PYNK program for young women facing breast cancer expands to two new locations
Sinai Health in Toronto and Juravinski Hospital and Cancer Centre in Hamilton recently celebrated the launch of their PYNK programs.
Thursday, September 15, 2022 Sunnybrook-led trial aims to treat prostate cancer with improved precision
A new Canadian trial designed and led by Sunnybrook Health Sciences Centre will determine whether Stereotactic Ablative Body Radiotherapy (SABR) can replace the standard brachytherapy boost for men with unfavourable risk prostate cancer.
